Who are Actithera's investors?

Actithera's investors include Hadean Ventures, Innovestor Ventures, M Ventures, Sofinnova Partners, 4BIO Capital, Bioqube Ventures.

How much funding has Actithera raised?

Actithera has disclosed $75.5M raised across 1 round.

Actithera

34 employees on LinkedIn · 9 known investors

Find your way into Actithera

Paths you didn't know you had: your email and LinkedIn already hold routes to the Actithera team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Darshan DalalChief Medical Officer

Investors · 9

Hadean Ventureslisted by Hadean VenturesOslo

How we know: Hadean Ventures's portfolio page · funding news · biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us

Innovestor Ventureslisted by Innovestor VenturesHelsinki · $270K – $3.2M

How we know: Innovestor Ventures's portfolio page · Not right? Tell us

M Ventureslisted by M VenturesAmsterdam · $10.8M

How we know: M Ventures's portfolio page · a partner's Signal profile · biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us

Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · funding news · biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us

4BIO CapitalreportedLondon

How we know: a partner's Signal profile · funding news · biospace.com · Not right? Tell us

Bioqube VenturesreportedBrussels · $108K – $6.5M

How we know: biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 3

Arkin Bio Ventures IIInnovestor's Life Science FundSurveyor Capital

Funding

SEC filings, press & company announcements

$75.5M disclosed across 1 round · 2025

$75.5Mseries AJul 2025 · 3 sources
4BIO Capital (lead), Hadean Ventures (lead), M Ventures (lead), Sofinnova Partners (lead), Arkin Bio Ventures II, Bioqube Ventures, Innovestor's Life Science Fund, Surveyor Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Actithera Raises $75.5M in Series A Fundingfinsmes.com · Jul 2025

Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapyprnewswire.com · Jul 2025

Actithera Raises $75.5M To Play in Sizzling Radiopharma Space - BioSpacebiospace.com · Jul 2025

Frequently asked questions

What does Actithera do?: Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.
Who are Actithera's investors?: Actithera's investors include Hadean Ventures, Innovestor Ventures, M Ventures, Sofinnova Partners, 4BIO Capital, Bioqube Ventures.
How much funding has Actithera raised?: Actithera has disclosed $75.5M raised across 1 round.